Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-25-325257
Filing Date
2025-12-18
Accepted
2025-12-18 17:49:12
Documents
1
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3685
  Complete submission text file 0001193125-25-325257.txt   5289
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Reporting) CIK: 0001434265 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37773 | Film No.: 251584445
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address YALELAAN 62 3584 CM UTRECHT DE
Business Address YALELAAN 62 3584 CM UTRECHT DE 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)